Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | HRH2 | P25021 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24565359 | 1.00 | CYP2C19 (0.36) | CYP2C19MAPTLMNAHSD17B10CYP3A4 | |
| SCHEMBL24565313 | 0.98 | LMNA (0.34) | CYP2C19MAPTLMNAHSD17B10CYP3A4 | |
| SCHEMBL24565371 | 0.94 | ALDH1A1 (0.35) | LMNAHSD17B10CYP3A4MEN1KMT2A | |
| SCHEMBL19419830 | 0.78 | CYP3A4 (0.38) | CYP2C19MAPTLMNAHSD17B10CYP3A4 | |
| SCHEMBL24565300 | 0.78 | CYP3A4 (0.38) | CYP2C19MAPTLMNAHSD17B10CYP3A4 | |
| SCHEMBL4811105 | 0.77 | LMNA (0.36) | MAPTLMNAHSD17B10CYP3A4ABCB11 | |
| SCHEMBL2336866 | 0.76 | KMT2A (0.36) | CYP2C19MAPTLMNAHSD17B10CYP3A4 | |
| SCHEMBL24565293 | 0.76 | F10 (0.38) | CYP2C19MAPTLMNAHSD17B10CYP3A4 | |
| SCHEMBL4811203 | 0.76 | F10 (0.41) | LMNAHSD17B10CYP3A4ALDH1A1ACHE | |
| SCHEMBL4812872 | 0.75 | LMNA (0.35) | MAPTLMNAHSD17B10CYP3A4ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12240810-B2 | Chiral-substituted poly-N-vinylpyrrolidinones and complexes with bimetallic nanoclusters and uses thereof in asymmetric oxidation reactions | KANSAS STATE UNIVERSITY RESEARCH (US) | 2025-03-04 | — | — | US | disclosed |
| US-20220204447-A1 | CHIRAL-SUBSTITUTED POLY-N-VINYLPYRROLIDINONES AND COMPLEXES WITH BIMETALLIC NANOCLUSTERS AND USES THEREOF IN ASYMMETRIC OXIDATION REACTIONS | NATIONAL SCIENCE FOUNDATION | 2022-06-30 | — | — | US | disclosed |
| US-20220204447-A1 | CHIRAL-SUBSTITUTED POLY-N-VINYLPYRROLIDINONES AND COMPLEXES WITH BIMETALLIC NANOCLUSTERS AND USES THEREOF IN ASYMMETRIC OXIDATION REACTIONS | NATIONAL SCIENCE FOUNDATION | 2022-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204447-A1 | CHIRAL-SUBSTITUTED POLY-N-VINYLPYRROLIDINONES AND COMPLEXES WITH BIMETALLIC NANOCLUSTERS AND USES THEREOF IN ASYMMETRIC OXIDATION REACTIONS | DHPS, PCBP1, PNKP | CYP2C19 567/4885MAPT 3111/4885LMNA 3416/4885 |
| US-12240810-B2 | Chiral-substituted poly-N-vinylpyrrolidinones and complexes with bimetallic nanoclusters and uses thereof in asymmetric oxidation reactions | DHPS, PCBP1, PNKP | CYP2C19 567/4885MAPT 3111/4885LMNA 3416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.